Please provide your email address to receive an email when new articles are posted on . VTE risk among women varied based on the type of hormonal contraceptive they used. These trends persisted ...

NEW YORK — Gov. Kathy Hochul and New York State Health Commissioner Dr. James McDonald recently signed a standing order authorizing pharmacists to dispense three types of hormonal contraception ...

A new study has linked most hormonal contraceptives to a higher risk of heart attacks and strokes. The paper, published in the British Medical Journal, looked at the prescription records of more than ...

Using hormonal contraception like birth control pills and intrauterine devices can come with side effects, though most doctors say the risk of severe problems is low. But in a new report published in ...

The long-acting progestogen injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate have been found to adversely affect bone mineral density in adult premenopausal ...

This cohort study found associations between hormonal contraceptives and depression risk among first-time moms in the first year postpartum. Researchers found that initiating hormonal contraception ...

Weight gain is commonly cited as a side effect of hormonal contraception, and may lead to discontinuation or reluctance to initiate. This view is widely held among clients and providers. Combination ...

The VTE rate ratios were significantly greater for all forms of hormonal contraception, except for progestin-only pills, compared with non-use. Venous thromboembolism (VTE) continues to be a risk ...

Strokes and heart attacks are rare for women with diabetes who use hormonal contraception, with the safest options being intrauterine devices (IUDs) and under-the-skin implants, new research published ...

Heritable traits and environmental factors influence the immune system in unknown ways. While the systemic immune system has received researchers' attention, little is understood about what variables ...

Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A ...